{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:30:09Z","timestamp":1792153809514,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,2]],"date-time":"2027-01-02T00:00:00Z","timestamp":1798848000000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01-EY031315"],"award-info":[{"award-number":["R01-EY031315"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.oret.2025.06.014","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T11:06:49Z","timestamp":1751022409000},"page":"81-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Analysis of Aqueous Interleukin-6 in Diabetic Retinopathy"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0592-0912","authenticated-orcid":false,"given":"Abhiram R.","family":"Manda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8562-348X","authenticated-orcid":false,"given":"Lok Hin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan S.","family":"Steinkerchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Veach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapna","family":"Gangaputra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7861-1563","authenticated-orcid":false,"given":"Stephen J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2025.06.014_bib1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.oret.2025.06.014_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.preteyeres.2011.05.002","article-title":"Inflammation in diabetic retinopathy","volume":"30","author":"Tang","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oret.2025.06.014_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00281-008-0111-x","article-title":"Immunological mechanisms in the pathogenesis of diabetic retinopathy","volume":"30","author":"Adamis","year":"2008","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.oret.2025.06.014_bib4","article-title":"Nonsteroidal anti-inflammatory drugs for retinal disease","volume":"2013","author":"Schoenberger","year":"2013","journal-title":"Int J Inflam"},{"key":"10.1016\/j.oret.2025.06.014_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.survophthal.2009.07.005","article-title":"Nonsteroidal anti-inflammatory drugs in ophthalmology","volume":"55","author":"Kim","year":"2010","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.oret.2025.06.014_bib6","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamaophthalmol.2013.6203","article-title":"Reduction of interleukin 8 and platelet-derived growth factor levels by topical ketorolac, 0.45%, in patients with diabetic retinopathy","volume":"132","author":"Schoenberger","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2025.06.014_bib7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.exer.2010.07.011","article-title":"Ketorolac inhibits choroidal neovascularization by suppression of retinal VEGF","volume":"91","author":"Kim","year":"2010","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.oret.2025.06.014_bib8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int Immunol"},{"key":"10.1016\/j.oret.2025.06.014_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005077","article-title":"Inflammatory biomarkers interleukin-6 and C-reactive protein and outcomes in stable coronary heart disease: experiences from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) trial","volume":"6","author":"Held","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.oret.2025.06.014_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2024.107008","article-title":"A novel biomarker of interleukin 6 activity and clinical and cognitive outcomes in depression","volume":"164","author":"Foley","year":"2024","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.oret.2025.06.014_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9394(01)01269-7","article-title":"Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema","volume":"133","author":"Funatsu","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2025.06.014_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ophtha.2008.09.037","article-title":"Association of vitreous inflammatory factors with diabetic macular edema","volume":"116","author":"Funatsu","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.06.014_bib13","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1111\/aos.14891","article-title":"Changes in aqueous and vitreous inflammatory cytokine levels in diabetic macular oedema: a systematic review and meta-analysis","volume":"100","author":"Minaker","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2025.06.014_bib14","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/s41433-024-03015-2","article-title":"Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy","volume":"38","author":"Sepah","year":"2024","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.oret.2025.06.014_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.26502\/fjor.2644-002400101","article-title":"Inflammatory Mediators in the Pathophysiology of Diabetic Retinopathy (INSPIRE): study design and baseline characteristics","volume":"8","author":"Gangaputra","year":"2025","journal-title":"J Ophthalmol Res"},{"key":"10.1016\/j.oret.2025.06.014_bib16","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales","volume":"110","author":"Wilkinson","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.06.014_bib17","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1167\/iovs.12-10410","article-title":"Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines","volume":"53","author":"Schoenberger","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2025.06.014_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1167\/iovs.10-6319","article-title":"Reduced choroidal neovascular membrane formation in cyclooxygenase-2 null mice","volume":"52","author":"Rezaei","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2025.06.014_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/archopht.119.4.547","article-title":"How many steps of progression of diabetic retinopathy are meaningful? The Wisconsin epidemiologic study of diabetic retinopathy","volume":"119","author":"Klein","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2025.06.014_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/APO.0000000000000468","article-title":"Optical coherence tomography classification systems for diabetic macular edema and their associations with visual outcome and treatment responses - an updated review","volume":"11","author":"Hui","year":"2022","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.oret.2025.06.014_bib21","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1096\/fj.03-1476fje","article-title":"A central role for inflammation in the pathogenesis of diabetic retinopathy","volume":"18","author":"Joussen","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.oret.2025.06.014_bib22","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.oret.2025.06.014_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0161-6420(95)30973-6","article-title":"Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group","volume":"102","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.06.014_bib24","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/db07-1618","article-title":"Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial\u2014revisited","volume":"57","author":"Lachin","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.oret.2025.06.014_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.956795","article-title":"Interleukin-6 inhibition in the treatment of autoinflammatory diseases","volume":"13","author":"Koga","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.oret.2025.06.014_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ophtha.2016.11.034","article-title":"Long-term effects of intravitreal 0.19 mg fluocinolone acetonide implant on progression and regression of diabetic retinopathy","volume":"124","author":"Wykoff","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.06.014_bib27","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ophtha.2010.12.028","article-title":"Long-term benefit of sustained-delivery fluocinolone acetonide vitreous inserts for diabetic macular edema","volume":"118","author":"Campochiaro","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.06.014_bib28","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ophtha.2021.07.009","article-title":"Intravitreal pharmacotherapies for diabetic macular edema: a report by the American Academy of Ophthalmology","volume":"129","author":"Ehlers","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2025.06.014_bib29","article-title":"Ocular side effects of antirheumatic medications: a qualitative review","volume":"5","author":"M Castillejo Becerra","year":"2020","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.oret.2025.06.014_bib30","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.3390\/ijms24054676","article-title":"Interleukin-6 and macular edema: a review of outcomes with inhibition","volume":"24","author":"Yang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.oret.2025.06.014_bib31","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.3390\/jcm12165232","article-title":"Normative data for macular thickness and volume for optical coherence tomography in a diabetic population without maculopathies","volume":"12","author":"Arruabarrena","year":"2023","journal-title":"J Clin Med"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025002970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653025002970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:51:54Z","timestamp":1768441914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653025002970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2468653025002970"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2025.06.014","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of Aqueous Interleukin-6 in Diabetic Retinopathy","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2025.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}